ABT sold $2.4B of COVID-19 diagnostics during 4Q20! https://abbott.mediaroom.com/2021-01-27-Abbott-Reports-Fourth-Quarter-2020-Results-Issues-Strong-Double-Digit-Growth-Forecast-for-2021 Non-GAAP EPS guidance for 2021 is >=$5.00, +37% (or more) relative to 2020’s $3.65.